- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 46.14M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $8.74M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $9.58M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.2M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.87M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $10.4M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $19M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $19.13M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $27.22M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $27.22M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 45.71M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$346.72K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $19.12M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $20.35M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.04 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.04 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.36M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.48M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.94M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.96M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $5.1M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $3.09M |
| Revenue | Q1 2025 · Mar 31, 2024 | $8.2M |